BaseSpace
Correlation
Engine-Public
Sign In
Register
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
T cell receptor signaling pathway
,
Lung cancer
,
Kidney
,
DNA fingerprint
,
Tamoxifen
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Columba livia
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
No studies found
Explore Curated Studies Results
Literature
Most Relevant Literature
Analysis of the Leishmania peroxin 7 interactions with peroxin 5, peroxin 14 and PTS2 ligands.
Mutagenesis of tGCN5 core region reveals two critical surface residues F90 and R140.
A prolactin-inducible gene product which is a member of the calpactin/lipocortin family.
Structural and functional divergences of the columbid annexin I-encoding cp37 and cp35 genes.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Pigeon Peas (Cajanus Cajan) : a Natural Anti-inflammatory Facilitating Weight Loss in Obese Patients…
Bronchoalveolar Immune Response Determination
Research for Specific Proteins of Interest for the Serological Diagnosis of Bird Fancier's Lung
Study of GC1008 in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Evaluation of Risk Minimization, Assessment and Outcomes in Patients With Chronic Pain Taking Avinza
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ